Results 141 to 150 of about 9,430 (168)

Golimumab

Reactions Weekly, 2018
  +5 more sources

Golimumab

Reactions Weekly, 2023
openaire   +2 more sources

Golimumab

Reactions Weekly, 2022
  +4 more sources

Golimumab

Reactions Weekly, 2019
  +4 more sources

Golimumab

Reactions Weekly, 2015
openaire   +2 more sources

Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study

United European Gastroenterology Journal, 2021
Daniela Pugliese, Giuseppe Privitera, Anna Viola   +2 more
exaly  

Golimumab pharmacokinetics in ulcerative colitis: a literature review

Therapeutic Advances in Gastroenterology, 2017
Josselin Rigaill, Nicolas Williët, Stéphane Paul   +2 more
exaly  

A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis

Digestive and Liver Disease, 2020
Fabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries   +2 more
exaly  

Variability in Golimumab Exposure: A ‘Real-Life’ Observational Study in Active Ulcerative Colitis

Journal of Crohn's and Colitis, 2016
Iris Detrez, Erwin Dreesen, Thomas Van Stappen   +2 more
exaly  

Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis

Seminars in Arthritis and Rheumatism, 2017
Florenzo Iannone, Romano Bucci, Fabio Cacciapaglia   +2 more
exaly